FGFR2+ tumors also demonstrated separation between both CD4+ T cells and CD8+ T cells and tumor cells as compared to both IDH1+ iCCA and FGFR2 WT/IDH1 WT (p<0.001) (Figure 5B). This evidence concerns the gene FGFR2 and neoplasm.